What is TKL Research?
Established in 1944 and headquartered in Fair Lawn, New Jersey, TKL Research operates as a comprehensive clinical research organization (CRO). The firm provides essential services to the pharmaceutical, biotechnology, medical device, and consumer healthcare industries. With decades of experience, TKL Research acts as a critical partner for companies navigating the complex regulatory and testing requirements necessary to bring life-saving products to market. Its market position is defined by a blend of historical expertise and modern clinical methodology, allowing it to serve as a reliable intermediary in the global healthcare supply chain.
How much funding has TKL Research raised?
TKL Research has raised a total of $2.6M across 2 funding rounds:
Debt
$1M
Debt
$1.6M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.6M led by PPP
Key Investors in TKL Research
PPP
Public-Private Partnership
What's next for TKL Research?
With the recent influx of capital, TKL Research is well-positioned to scale its enterprise-level operations and enhance its technological infrastructure. The strategic focus will likely shift toward expanding its clinical trial capabilities and integrating advanced data analytics to meet the evolving demands of the biotech and medical device sectors. As the company moves forward, this financial foundation will be instrumental in maintaining its competitive edge, fostering innovation in patient-centric research, and navigating the increasingly rigorous global regulatory environment. The firm remains a pivotal entity for stakeholders looking to capitalize on the intersection of clinical rigor and market-ready healthcare solutions.
See full TKL Research company page
